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Rebola, Nelson, Ana M. Sebastia˜o, Alexandre de Mendonc¸a, Ca-
tarina R. Oliveira, J. A. Ribeiro, and Rodrigo A. Cunha. Enhanced
adenosine A2a receptor facilitation of synaptic transmission in the
hippocampus of aged rats. J Neurophysiol 90: 1295–1303, 2003;
10.1152/jn.00896.2002. Adenosine either inhibits or facilitates syn-
aptic transmission through A1 or A2A receptors, respectively. Since
A2A receptor density increases in the limbic cortex of aged (24 mo)
compared with young adult rats (2 mo), we tested if A2A receptor
modulation of synaptic transmission was also increased in aged rats.
The A2A receptor agonist, CGS21680 (10 nM), caused a larger facil-
itation of the field excitatory postsynaptic potential (fEPSP) slope in
hippocampal slices of aged (38%) than in young rats (19%), an effect
prevented by the A2A receptor antagonist, ZM241385 (20 nM). In
contrast to young rats, where CGS21680 facilitation of fEPSPs is
prevented by the protein kinase C inhibitor, chelerythrine (6 M), but
not by the protein kinase A inhibitor, H-89 (1 M), the CGS21680-
induced facilitation of fEPSP slope in aged rats was prevented by
H-89 (1 M) but not by chelerythrine (6 M). Also, in contrast to the
receptor agonist, isoproterenol (30 M), CGS21680 (100–1,000
nM) enhanced cAMP levels in hippocampal nerve terminals of aged
but not young rats. Finally, we observed a significant increase of both
the binding density of [3H]CGS 21680 and the [3H]ZM241385 as well
as of the anti-A2A receptor immunoreactivity in hippocampal nerve
terminal membranes from aged compared with young rats. This shows
that A2A receptor-mediated facilitation of hippocampal synaptic trans-
mission is larger in aged than young rats due to increased A2A
receptor density in nerve terminals and to the modified transducing
system operated by A2A receptors, from a protein kinase C mediated
control of A1 receptors into a direct protein kinase A dependent
facilitation of synaptic transmission.
I N T R O D U C T I O N
Maintenance of CNS homeostasis with aging represents a
major challenge, since neuronal cells cannot generally be re-
placed during the lifetime of an individual. Thus the nervous
system has to find strategies to cope with the decreased effi-
ciency of neuronal performance, similar to that occurring in
CA1 hippocampal circuits (Barnes 1994; Barnes et al. 2000)
that results from the general age-induced compromise of cel-
lular function (Dani et al. 1997). The more direct approach to
enhance excitatory transmission would be to use analogues of
the main excitatory neurotransmitter in the brain, but glutamate
analogues can also produce excitotoxic effects (Rothman
1984). An indirect approach is to interfere with neuromodula-
tory systems of glutamatergic transmission since they fine-tune
transmission rather than support information processing.
One ubiquitous neuromodulatory system in the CNS is op-
erated by adenosine. Adenosine neuromodulation is mostly
conceived as an inhibitory system that restrains excitatory
transmission through activation of inhibitory A1 receptors
(Dunwiddie and Masino 2001). However, neurons are
equipped with other adenosine receptors, mainly A2A recep-
tors, whose activation results in a facilitation of neurotransmit-
ter release (Cunha 2001). The search of the physiological
relevance of these A2A receptors has given rise to the idea that
they mostly act to fine-tune other neuromodulatory systems
(Sebastia˜o and Ribeiro 2000) and, among others, to control the
tonic inhibitory action of A1 receptors (Lopes et al. 1999a).
Thus the control by adenosine of neurotransmitter release
should be conceived as a balance between inhibitory A1 and
facilitatory A2A receptor-mediated actions (Cunha 2001).
This potential for adenosine to either inhibit or facilitate
synaptic transmission makes this neuromodulatory system a
likely candidate to be reset to compensate the age-related
changes in neuronal performance. In fact, previous studies
have shown a decrease in the density of A1 receptors and an
increase in the density of A2A receptors in the limbic cortex
and neocortex of aged rats (Cunha et al. 1995a). This decrease
in the density of A1 receptors is accompanied by a decreased
ability of A1 receptor agonists to inhibit synaptic transmission
in the hippocampus of aged rats (Sebastia˜o et al. 2000). Also,
the increased density of A2A receptors is accompanied by a
greater efficiency of A2A receptors to enhance acetylcholine
release from hippocampal preparations (Lopes et al. 1999b).
However, the role of A2A receptors in the control of acetyl-
choline release appears to be different from the A2A receptor-
mediated facilitation of glutamatergic transmission in young
adult rats. Thus the A2A receptor-mediated facilitation of ace-
tylcholine release is independent of A1 receptor function
(Cunha et al. 1995b) and involves activation of protein kinase
A (Rebola et al. 2002), whereas the A2A receptor-mediated
facilitation of glutamatergic transmission results from a desen-
sitization of tonic A1 receptor-mediated inhibition of synaptic
transmission (Lopes et al. 2002) and involves activation of
protein kinase C (Cunha and Ribeiro 2000). Thus we now
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investigated if the A2A receptor-mediated modulation of syn-
aptic transmission is modified in hippocampal slices of aged
rats.
We found that there is an increased ability of A2A receptors
to facilitate synaptic transmission in the hippocampus of aged
rats and that this effect of A2A receptors in aged rats is no
longer due to a protein kinase C mediated attenuation of A1
receptor tonic inhibition (Cunha and Ribeiro 2000; Lopes et al.
1999a, 2002) but rather to a protein kinase A mediated direct
facilitation of synaptic transmission.
M E T H O D S
1,3-Dipropyl-8-cyclopentyladenosine (DPCPX), 2-[4-(2-p-carboxy-
ethyl)phenylamino]-5-N-ethylcarboxamidoadenosine (CGS21680), 8-{4-
[(2-aminoethyl)amino]carbonylmethyl-oxyphenyl}xanthine (XAC), and
bisindolylmaleimide were from RBI (Natick, MA); chelerythrine and
N-[2-((p-bromocinnamyl)amino)ethyl]5-isoquinolinesulfonamide (H-89)
were from Calbiochem (Darmstadt, Germany); adenosine, 2-chloroad-
enosine, and isoproterenol were from Sigma (Reagente 5, Portugal);
4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin-5-ylamino]
ethyl)phenol (ZM241385) and [3H]ZM241385 (specific activity, 17
Ci/mmol) were from Tocris Cookson (Bristol, UK); [3H]CGS21680
(specific activity, 37.5 Ci/mmol) was from New England Nuclear
(Anagene, Portugal); goat purified IgG anti-adenosine A2A receptor
antibody (200 g/ml) was from Santa Cruz Biotechnology-Europe;
rolipram [4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (4-
RS)] was a gift of Schering AG; and [3H]-5-amino-7-(2-phenylethyl)-
2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
([3H]SCH58261, specific activity, 77 Ci/mmol) was a generous gift of
Dr. Ennio Ongini (Shering-Plough, Milan). Adenosine deaminase
(1914 U/ml, EC 3.5.4.4) was purchased from Boehringer (Dorset,
UK), in a suspension in 50% (vol/vol) glycerol in potassium phos-
phate (pH 6.0) and dilutions of this suspension were used, together
with appropriate corrections of glycerol and KH2PO4 content of all
control solutions.
Adenosine, 2-chloroadenosine, CGS21680, chelerythrine, H-89,
and ZM241385 were made up to a 5 mM stock solution in dimeth-
ylsulfoxide; rolipram was made up in a 50 mM stock solution in
dimethylsulfoxide and DPCPX was made up into 5 mM stock in 99%
dimethylsulfoxide and 1% NaOH 1 M. These stock solutions were
aliquoted and stored at 20°C and aqueous dilution of these stock
solutions was made daily.
Animals
Male Wistar rats from the Gulbenkian Institute animal house or
from Harlan Iberica were used throughout this study. Young adult rats
were 6 weeks old (140–160 g), whereas aged rats were 21–24 mo old
(950–1,080 g). In some experiments, 18-mo-old rats were used (960–
1,020 g). Most studies in purinergic modulation have been performed
in 6-weeks-aged rats, which are considered juvenile or young adult
rats, whereas 18- to 24-mo-old rats are considered aged rats (i.e., close
to the limit of life expectancy; Masoro 1991; Miller and Nadon 2000).
Indeed, around 30% of the initial population of rats allocated for this
study did not reach this age range, confirming by operational criteria
that rats 18–24 mo old are aged rats (see Masoro 1991). In neither
group of aged rats was there any evidence of gross anatomical lesions
in the brain. The handling and use of these animals was according the
EU guidelines for use of experimental animals, the animals being
anesthetized under halothane atmosphere before being killed by de-
capitation. The number of animals used was kept to the absolute
minimum, with care not to use more animals than these required to
obtain statistically significant results.
Electrophysiological recordings of hippocampal
synaptic transmission
One 400-m hippocampal slice, obtained as previously described
(e.g., Lopes et al. 1999a), was transferred to a 1-ml recording chamber
for submerged slices and continuously superfused, at a flow rate of 3
ml/min, with gassed (95% O2-5% CO2) Krebs solution, kept at 30°C,
of the following composition (in mM): 125 NaCl, 3 KCl, 1.25
NaH2PO4, 25 NaHCO3, 2 CaCl2, 1 MgSO4, and glucose 10, pH 7.4.
Drugs were added to this superfusion solution. Electrophysiological
recordings of field excitatory postsynaptic potentials (fEPSP) were
obtained as previously described (e.g., Sebastia˜o et al. 2000). Stimu-
lation (rectangular pulses of 0.1 ms applied once every 15 s) was
delivered through a bipolar concentric electrode placed on the Schaf-
fer fibers, in the stratum radiatum near the CA3/CA1 border. Ortho-
dromically evoked fEPSPs were recorded through an extracellular
microelectrode (4 M NaCl, 2–5 M resistance) placed in the stratum
radiatum of the CA1 area. The intensity of the stimulus [which was
similar in hippocampal slices from young adult (220  40 A, n 
7) and aged rats (290  30 A, n  14)] was adjusted to evoke a
fEPSP with an amplitude of 0.7–1 mV without appreciable population
spike contamination. Recordings were obtained with an Axoclamp 2B
amplifier coupled to a DigiData 1200 interface (Axon Instruments,
Foster City, CA) and averages of eight consecutive responses were
continuously monitored on a personal computer with the LTP 1.01
software (Anderson and Collingridge 1997). Responses were quanti-
fied as the initial slope of the averaged fEPSPs and the effect of drugs,
added to this superfusion solution, was estimated by changes in the
fEPSP slope compared with baseline.
A2A receptor binding to hippocampal nerve
terminals membranes
[3H]CGS21680 or [3H]ZM241385 binding studies were performed
as previously described (e.g., Cunha et al. 1995a, 1997) using mem-
branes from hippocampal nerve terminals (see e.g., Lopes et al.
1999a). Briefly, [3H]CGS21680 (60 nM) binding was for 4 h;
[3H]ZM241385 (2 nM) binding was for 60 min, and [3H]SCH58261
(10 nM) was for 60 min at room temperature (23–25°C), with 282–
384 g of membrane protein in a final volume of 300 l in an
incubation solution containing 50 mM Tris-HCl and 10 mM MgCl2,
pH 7.4, with 5 U/ml adenosine deaminase. Specific binding was
determined by subtraction of the nonspecific binding, which was
measured in the presence of 2 M XAC. The binding reactions were
stopped by vacuum filtration through Whatman GF/C glass fiber
filters, followed by washing of the filters and reaction tubes with 10 ml
of the incubation solution, kept at 4°C. The filters were then placed in
scintillation vials, and 5 ml of scintillation liquid (Scintran Cocktail T,
Wallac, Pharmacia-Portugal) was added. Radioactivity bound to the
filters was determined after 12 h with an efficiency of 55–60% for 2
min. Binding assays were performed in duplicate. Membrane protein
was determined according to Peterson (1977).
cAMP assays in hippocampal nerve terminals
Hippocampal synaptosomes were prepared as previously described
(e.g., Cunha et al. 1995b) and resuspended in 1 ml gassed Krebs
solution also containing 2 U/ml adenosine deaminase and 50 M
rolipram. A 90-l synaptosomal aliquot was warmed at 37°C for 15
min and then incubated at 37°C for 4 min with gassed Krebs contain-
ing adenosine deaminase and rolipram (control) or with this modified
Krebs containing isoproterenol (30 M) or CGS21680 (30–1,000
nM) without or with ZM241385 (20 nM). The treated synaptosomes
were then inactivated by boiling for 10 min in 1 ml of 50 mM Tris/4
mM EDTA, pH 7.6. The levels of cAMP in the supernatants obtained
after sonication and centrifugation (14,000 g, 10 min, 4°C) were
quantified with a radioimmunoassay kit (Amersham), as previously
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described (Lopes et al. 1999b), and protein was measured according to
Peterson (1977).
Western blot analysis of A2A receptor immunoreactivity in
hippocampal nerve terminals
The analysis of adenosine A2A receptor immunoreactivity was
carried out as previously described (Rebola et al. 2002) in membranes
from a Percoll-purified synaptosomal fraction of the hippocampus
(e.g., Lopes et al. 1999a). Briefly, after determining the amount of
protein (Spector 1978), each sample was diluted with two volumes of
a solution containing 8 M urea, 100 mM dithiothreitol, 2% (wt/vol)
sodium dodecyl sulfate, and 375 mM Tris-HCl pH 6.8 and incubated
for 2 h at 37°C. These diluted samples and the prestained molecular
weight markers (Amersham) were separated by sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (10% with a 4% concentrat-
ing gel) under reducing conditions and electro-transferred to polyvi-
nylidene difluoride membranes (0.45 m from Amersham). After
blocking for 2 h at room temperature with 5% milk in Tris-buffered
saline, pH 7.6 containing 0.1% Tween 20 (TBS-T), the membranes
were incubated overnight at 4°C with the goat IgG anti-adenosine A2A
receptor antibody (1:100 dilution). After four washing periods for 10
min with TBS-T containing 0.5% milk, the membranes were incu-
bated with the alkaline phosphatase conjugated rabbit anti-goat IgG
secondary antibody (1:2,000 dilution from Calbiochem) in TBS-T
containing 1% milk for 90 min at room temperature. After five 10-min
washes in TBS-T containing 0.5% milk, the membranes were incu-
bated with Enhanced Chemi-Fluorescence for 5 min and then ana-
lyzed with a Storm (Molecular Devices).
Statistics
The values presented are mean  SE of n experiments. To test the
significance of the effect of a drug versus control, a paired Student’s
t-test was used. When making comparisons from different sets of
experiments with control, ANOVA was used, followed by Dunnett’s
test. P  0.05 was considered to represent a significant difference.
R E S U L T S
Modification of adenosine A2A receptor modulation of
synaptic transmission in the hippocampus of aged rats
Since there is an increase in the number of CGS21680
binding sites in the hippocampus of aged rats (Cunha et al.
1995a), we investigated whether there was also an increased
efficiency of A2A receptors to modulate hippocampal synaptic
transmission in aged rats. A single concentration (10 nM) of
the A2A receptor agonist, CGS21680, was tested, since it
produces a maximal facilitation of synaptic transmission in
young adult animals (Cunha et al. 1997). In the present set of
experiments, CGS21680 (10 nM) caused a facilitation of 19 
2% (n  5) in young adult rats and a greater facilitation (38 
6%, n 8, P 0.05) of fEPSP slope in aged rats (Fig. 1, A and
B). To compare the effect of CGS21680 between the two age
groups, a similar intensity of stimulation was used, which
caused a smaller fEPSP slope and amplitude in aged rats, as
previously observed (e.g., Bauman et al. 1992; Sebastia˜o et al.
2000); and, although input/output curves were not performed
in the two age groups, previous studies in young adult rats
suggested that the CGS21680-induced facilitation of synaptic
transmission is apparently not related to the strength of stim-
ulation (see Cunha et al. 1997; Cunha and Ribeiro 2000; Lopes
et al. 1999a, 2002). In 18-mo-old rats, CGS21680 (10 nM) caused
a 41 4% (n 4) facilitation of fEPSP slope, and, as illustrated
in Fig. 1C, this effect of CGS21680 was prevented by the
adenosine A2A receptor antagonist, ZM241385 (20 nM, n 3),
as has been shown to occur in young adult animals (Cunha et
al. 1997). ZM241385 (20 nM) was devoid of effects on syn-
aptic transmission in young rats, as well as in 18-mo-old rats
(n  3). It should be pointed out that although ZM241385 is
the best A2A receptor antagonist commercially available, it is
not an ideal tool to probe the role of tonic A2A receptor
activation by endogenous adenosine since it also interferes
with A1 receptor-mediated responses (Lopes et al. 1999c),
FIG. 1. Comparison of the effects of the adenosine A2A receptor agonist,
CGS21680 (10 nM), on glutamatergic transmission in hippocampal slices of
young adult (6 wk) and aged (24 mo) rats (A and B) and prevention of the effect
of CGS21680 (10 nM) by the A2A antagonist, 4-(2-[7-amino-2(2-
furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol (ZM241385;
20 nM), in aged (18 mo) rats (C). In A are shown averages of 8 consecutive
field excitatory postsynaptic potentials (fEPSPs) recorded from the CA1 area
of hippocampal slices from aged (a, b, and c) and young rats (d, e, and f). The
fEPSPs were obtained in a and d before adding any drug to the superfusion
solution, in b and e 20–24 min after application of CGS21680 (10 nM), and in
c and f 40–42 min after washing out the A2A receptor agonist. Calibration bars:
500 V, 10 ms. Note that the slope and amplitude of the fEPSPs in the aged
rats were lower than those recorded from young rats, as previously reported
(e.g., Bauman et al. 1992). In B, the ordinates represent the average percentage
increase of fEPSP slope caused by CGS21680 (10 nM) in slices from aged
(filled bar, n 8, control fEPSP slope of 0.33 0.03 mV/ms) and from young
adult rats (open bar, n 5, control fEPSP slope of 0.41 0.02 mV/ms). *P
0.05 vs. baseline; **P  0.05 between the 2 age groups. In (C) is shown a time
course of a representative experiment in a hippocampal slice from an aged rat (18
mo) which was first superfused with ZM241385 (20 nM); then with CGS21680
(10 nM) in the presence of ZM241385 (20 nM), the 2 drugs were washed out and
CGS21680 (10 nM) was re-applied, as shown in the horizontal bars.
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although it only interferes with A1 receptor binding in micro-
molar concentrations (Cunha et al. 1997).
Although in young adult rats it is possible to record facili-
tatory A2A receptor-mediated effects on synaptic transmission,
these facilitatory effects are not due to a direct facilitation of
synaptic transmission, but rather to an A2A receptor-induced
decrease of tonic A1 receptor-mediated inhibition of synaptic
transmission (Lopes et al. 1999a, 2002). Accordingly, super-
fusion of hippocampal slices from young adult rats with aden-
osine causes a concentration-dependent inhibition of synaptic
transmission that is blocked by effective concentrations of A1
receptor antagonists, such as DPCPX (e.g., Dunwiddie and
Diao 1994). As occurs in young adult rats, superfusion of
hippocampal slices of aged rats with adenosine (50 M) also
produced a nearly complete blockade of synaptic transmission
(Fig. 2). However, in contrast with what occurs in young adult
rats (Fig. 2A), in the presence of DPCPX (50 nM), adenosine
now increased the fEPSP slope in hippocampal slices of aged
rats (57.4  3.9%, n  4; P  0.05) (Fig. 2B). A close
chemical analogue of adenosine that is an agonist of all aden-
osine receptors and is less prone to metabolism, 2-chloro-
adenosine (10 M), also facilitated (66.9  7.4%, n  3, P 
0.05) fEPSP slope in the presence of DPCPX (50 nM) in aged
rats, excluding the possibility that modifications of adenosine
metabolism in aged rats (Cunha et al. 2001) might be respon-
sible for this effect (Fig. 2B). These facilitatory effects of
adenosine and 2-chloroadenosine recorded in the presence of
DPCPX (50 nM) in aged rats were attenuated by ZM241385
(20 nM), indicating the involvement of A2A receptor activation
(Fig. 2, B and C).
This observation that adenosine is able to facilitate synaptic
transmission in aged rats on blockade of inhibitory A1 recep-
tors further supports a greater functional impact of A2A recep-
tor activation in aged rats. Also, it indicates that the mechanism
by which A2A receptors facilitate synaptic transmission is
different in aged and in young adult rats. In fact, in young adult
rats, the A2A receptor-induced facilitation of synaptic transmis-
sion is blocked on removal of tonic A1 receptor-mediated
inhibition of synaptic transmission (Lopes et al. 1999a, 2002),
whereas in aged rats the A2A receptor-mediated facilitation of
synaptic transmission is independent of A1 receptor function.
Since A2A receptors can couple to different G proteins in
different systems (Cunha 2001), we explored the possibility
that there was a difference in the transducing systems operated
by A2A receptors in young adult and in aged rats.
Effect of A2A receptor activation on cAMP levels
in hippocampal nerve terminals
In young adult rats, A2A receptor-mediated facilitation of
hippocampal synaptic transmission is protein kinase C depen-
dent, but not protein kinase A dependent (Cunha and Ribeiro
2000). However, in several other systems, A2A receptors facil-
itate neurotransmitter release on increasing cAMP levels in
nerve terminals (Correia-de-Sa´ and Ribeiro 1994; Gubitz et al.
1996; Okada et al. 2001). Activation of A2A receptors causes a
greater accumulation of cAMP in cortical slices of aged com-
pared with young adult rats (Lopes et al. 1999b), but it is not
known if this also occurs in hippocampal nerve terminals.
Since we had previously observed that the concentration
range required to detect CGS21680-induced cAMP increases is
nearly 10-fold greater than that required to facilitate neuro-
transmitter release in other CNS preparations (Lopes et al.
1999b), we tested the effect of higher concentrations (30–
1,000 nM) of CGS21680 on cAMP levels. As shown in Fig.
3A, CGS21680 (30–1,000 nM) failed to modify cAMP levels
in rat hippocampal nerve terminals of young adult rats. In
contrast, in aged rats, CGS21680 enhanced cAMP levels in
hippocampal nerve terminals from a basal level of 5.2  0.9
pmol/mg protein (n  4) to a maximal level of 12.2  1.1
FIG. 2. Adenosine and 2-chloroadenosine facilitate glutamatergic transmis-
sion in hippocampal slices of aged (22 mo), but not young adult (6 wk), rats
on blockade of adenosine A1 receptors with 1,3-dipropyl-8-cyclopentyl-
adenosine (DPCPX; 50 nM), in a manner sensitive to the adenosine A2A
receptor antagonist, ZM241385 (20 nM). A and B: time courses of represen-
tative experiments presenting the averages of the slopes of 8 consecutive
fEPSPs recorded from the CA1 area of hippocampal slices from young adult
(A) and aged rats (B) showing that adenosine (50 M, labeled as 1) and
2-chloroadenosine (10 M, labeled as 2) nearly block the fEPSP in both young
adult and aged rats. However, in the presence of DPCPX (50 nM), the effect
of adenosine (50 M) and 2-chloroadenosine (10 M) is abolished in young
adult rats (A) but is converted into a facilitatory effect in aged rats (B) that is
prevented in the presence of ZM241385 (20 nM). Each drug was present when
indicated by the upper bars in A and B (1 indicates the presence of adenosine
and 2 indicates the presence of 2-chloroadenosine). In C, the ordinates repre-
sent the average percentage increase of fEPSP slope caused by adenosine (50
M) or by 2-chloroadenosine (10 M) in slices from aged rats (19–22 mo)
always in the presence of DPCPX (50 nM) and in the absence or in the
presence of ZM241385 (20 nM) as indicated under each bar (control fEPSP
slope of 0.36  0.04 mV/ms). *P  0.05 vs. 0%; **P  0.05 between
indicated bars.
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pmol/mg protein (n  4) at 300 nM CGS21680 (Fig. 3A). This
stimulatory effect of CGS21680 was mediated by A2A receptor
activation since ZM241385 (20 nM) attenuated the stimulatory
effect of CGS21680 (300 nM) on cAMP levels in hippocampal
nerve terminals of aged rats (Fig. 3A). It should be noted that
the basal levels of cAMP were lower in nerve terminals of aged
compared with young adult rats, as previously observed in
different brain preparations (Lopes et al. 1999b; Zimmerman
and Berg 1974). This is an indication that the tonic activation
of A2A receptors is not a receptor system responsible for the
control of basal cAMP levels in hippocampal nerve terminals.
To test if this A2A receptor-induced increase in cAMP was
due to an increased efficiency of A2A receptors rather than to a
general responsiveness of adenylate cyclase-coupled receptor
in hippocampal nerve terminals from aged rats, we compared
the ability of the adrenergic receptor agonist, isoproterenol,
to increase cAMP levels in hippocampal nerve terminals of
young adult and aged rats, since receptor activation in-
creases cAMP in rat cortical nerve terminals (Herrero and
Sanchez-Prieto 1996). As shown in Fig. 3B, isoproterenol (30
M) caused a nearly similar increase of cAMP levels in young
adult (58.2  5.2 pmol/mg protein, n  4) and in aged rat
hippocampal nerve terminals (46.6  4.1 pmol/mg protein,
n  4).
Transducing system operated by A2A receptors to facilitate
synaptic transmission in aged rats
The findings that A2A receptor-mediated facilitation of hip-
pocampal synaptic transmission in aged rats occurred indepen-
dently of A1 receptors and that A2A receptors triggered cAMP
accumulation in aged hippocampal nerve terminals led us to
test if A2A receptors facilitated hippocampal synaptic transmis-
sion in aged rats via an adenylate cyclase/cAMP/protein kinase
A pathway, or through a protein kinase C pathway, as has been
observed in young adult rats (Cunha and Ribeiro 2000).
Figure 4A shows time-course recordings of synaptic trans-
mission in hippocampal slices from aged rats that illustrate the
ability of the protein kinase A inhibitor, H-89 (1 M), to
prevent the facilitatory effects of CGS21680 (10 nM), and the
ability of the protein kinase C inhibitor, chelerythrine (6 M),
only to attenuate the facilitatory effect of CGS21680 (10 nM).
In the average of three experiments, CGS21680 (10 nM)
caused a 67.6  18.7% facilitation of fEPSP slope and this
effect was attenuated by 26.5  9.5% by chelerythrine (6 M)
and by 81.2  2.1% by H-89 (1 M) (Fig. 4B). In a fourth
experiment in aged rats, CGS21680 increased fEPSP slope by
48% and this facilitatory effect was attenuated by 91% by H-89
(1 M) and only by 16% by another protein kinase C inhibitor,
bisindolylmaleimide (1 M). By themselves, chelerythrine (6
M) inhibited by 16  3% fEPSP slope in aged rats, whereas
H-89 (1 M) was virtually devoid of effects (5  4% inhibi-
tion of fEPSP slope, n  3).
Increase in the density of A2A receptors in hippocampal
nerve terminals of aged rats
The initial reason that led us to test if there was an increase
facilitatory effect of A2A receptor activation on hippocampal
synaptic transmission was the observation that there was an
increased density of A2A receptors in the hippocampus of aged
rats (Cunha et al. 1995a). This increase was measured in whole
membranes, whereas the A2A receptor facilitation of fEPSPs
and of cAMP levels in aged rats results from activation of
presynaptic A2A receptors. Thus it remained to be established
if there was also a proportionally greater increase in the density
of A2A receptors in hippocampal nerve terminals of aged rats.
For that purpose, we initially carried out binding studies with
an agonist and antagonist of A2A receptors, [3H]CGS21680 (60
nM) and [3H]ZM241385 (2 nM) (Cunha et al. 1997), in mem-
branes derived from synaptosomes prepared from the hip-
pocampus of young adult and aged rats. The data summarized
in Fig. 5, A and B, show that there was an increased density of
both [3H]CGS21680 (60 nM) and [3H]ZM241385 (2 nM)
binding to hippocampal nerve terminal membranes of aged
compared with young adult rats (n  4), which is proportion-
ally greater than that occurring in whole hippocampal mem-
branes (Cunha et al. 1995a).
Finally, we confirmed this increased density of A2A recep-
tors in membranes of hippocampal nerve terminals of aged rats
FIG. 3. Activation of A2A receptors increase the levels of cAMP in hip-
pocampal nerve terminals in aged but not in young adult rats, whereas the
activation of  adrenergic receptors leads to a similar increase in cAMP levels
in young adult and aged hippocampal nerve terminals. Rat hippocampal
synaptosomes (342–612 g protein) from young adult rats (6 wk, open
symbols and bars) or aged rats (19–22 mo, filled symbols and bars) were
incubated for 4 min with Krebs containing 2 U/ml adenosine deaminase and 50
M rolipram without or with the adenosine A2A receptor agonist, CGS21680
(30–1,000 nM), in the absence (circles) or in the presence of the A2A receptor
antagonist ZM241385 (20 nM, triangles) in (A) or with the adrenergic
receptor agonist, isoproterenol (30 M) in (B). The treated synaptosomes were
then inactivated and sonicated; their cAMP levels were quantified with a
radioimmunoassay kit and the values were normalized per mg of protein. In (A)
and (B) the ordinates represent the amounts of cAMP in nerve terminals. The
values are mean SE of 4 experiments performed in duplicate in both (A) and
(B). *P  0.05 vs. basal value; **P  0.05 versus absence of ZM241385 (20
nM) in (A).
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using Western blot analysis. As illustrated in Fig. 5C, there was
a more intense immuno-reactivity of the anti-adenosine A2A
receptor antibody in hippocampal nerve terminals from aged
compared with young adult rats. In three Western blots carried
out with membranes from three different groups of young adult
and aged rats, we observed a 76  6% increase in the densi-
tometrically measured immuno-reactivity in aged compared
with young adult rats.
Age-dependent increase in A2A receptor binding and A2A
receptor-induced cAMP accumulation
The results presented so far indicate that there is an in-
creased density of A2A receptors and a change in the transduc-
ing system operated by A2A receptors in the hippocampus of
aged rats. However, given that 20 mo is a relatively long time
window in a rat, it is not clear if the changes observed for the
neuromodulatory system operated by A2A receptors result from
a gradual change over life span or to a switch occurring
essentially in the aged rats. To address this question, we
investigated the changes in the density of A2A receptors and in
the ability of A2A receptor activation to increase cAMP levels
in nerve terminals from the hippocampus of rats at 0.5, 2, 6, 12,
18, and 24 mo.
As illustrated in Fig. 6A, the binding A2A receptor antago-
nist, [3H]SCH58261 (10 nM), was not statistically different
(P 0.05) in hippocampal nerve terminals membranes derived
from animals with ages ranging from 0.5 to 12 mo. However,
the specific binding of [3H]SCH58261 (10 nM) was signifi-
cantly (P  0.05) larger in hippocampal nerve terminals mem-
branes from 18-mo-old rats and did not further increase in rats
at 24 mo (Fig. 6A). Likewise, there was no significant (P 
FIG. 4. Comparison of the ability of the protein kinase A inhibitor, H-89 (1
M), and of the protein kinase C inhibitor, chelerythrine (6 M), to modify the
facilitatory effect of the adenosine A2A receptor agonist, CGS21680 (10 nM),
on synaptic transmission in rat hippocampal slices of aged rats. In (A) are
shown averages of the slopes of 8 consecutive fEPSPs recorded from the CA1
area of an hippocampal slice of an aged rat (21-mo-old) which was superfused
with CGS21680 (10 nM) in the absence and in the presence of either the
protein kinase A inhibitor, H-89 (1 M), or the protein kinase C inhibitor,
chelerythrine (6 M), as indicated by the upper bars. In B, the ordinates
represent the average percentage increase of fEPSP slope in hippocampal
slices from aged rats (19–21 mo) caused by CGS21680 (10 nM) in the absence
(control fEPSP slope of 0.31  0.06 mV/ms) and in the presence of either
H-89 (1 M) or chelerythrine (6 M). The results are mean  SE of 3
experiments. *P  0.05 vs. 0%; **P  0.05 between the indicated bars.
FIG. 5. Comparison of the specific binding of the A2A receptor agonist,
[3H]CGS21680 (60 nM, in A), of the A2A receptor antagonist, [3H]ZM241385
(2 nM, in B), and of A2A receptor immuno-reactivity (C) to membranes
prepared from synaptosomes derived from the hippocampus of young adult (6
wk, open bars in A and B) and aged rats (19- to 21-mo-old, filled bars in A and
B). In A and B, the ordinates represent the specific binding of either
[3H]CGS21680 (A) or [3H]ZM241385 (B) obtained on subtraction of the
nonspecific binding, determined in the presence of 2 M 8-{4-[(2-amino-
ethyl)amino]carbonylmethyl-oxyphenyl}xanthine (XAC), from total binding.
Results are mean  SE of 4 experiments performed in duplicate. C: Western
blot comparing the immuno-reactivity obtained with an anti-A2A receptor
antibody in hippocampal synaptosomal membranes from aged (22-mo-old;
first 2 lanes from left labeled as aged) and young adult rats (6-wk-old; first 2
lanes from right labeled as young), with 120 g of membrane protein being
applied in each lane.
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0.05) change induced by CGS21680 (300 nM) in the levels of
cAMP in nerve terminals from 0.5- to 6-mo-old rats. In 12-
mo-old rats, CGS21680 (300 nM) caused a small but signifi-
cant (P  0.05) increase in the levels of cAMP (Fig. 6B).
However, this CGS21680 (300 nM)-induced increase in the
levels of cAMP was considerably greater in hippocampal nerve
terminals derived from 18- and 24-mo-old rats (Fig. 6B).
D I S C U S S I O N
The main conclusion of the present work is that in aged rats
there is an increased ability of adenosine A2A receptors to
facilitate hippocampal synaptic transmission when compared
with young adult rats and that this is due both to an increase in
the binding density of A2A receptors in hippocampal nerve
terminals as well as to a difference in the main transducing
system operated by hippocampal A2A receptors. Thus in aged
rats, A2A receptors no longer facilitate hippocampal synaptic
transmission indirectly by attenuating tonic A1 receptor-medi-
ated inhibition, but they directly facilitate glutamatergic trans-
mission in a protein kinase A dependent manner on stimulation
of cAMP levels in nerve terminals. Although the conclusion
that there is a different pharmacology and transducing system
operated by A2A receptors mostly stems from comparison of
results now reported in aged rats with previously published
results in young adult rats (Cunha and Ribeiro 2000; Lopes et
al. 2002), all the experiments were carried out by the same
experimenter and in the same set-up with a 3- to 7-mo time
span, thus limiting possible bias of such cross-experiment
comparisons. It is of particular interest to note that, although
most of the study was designed to investigate the status of the
neuromodulatory system operated by A2A receptors in the
hippocampus of aged rats in comparison to young adult rats,
the study of the changes on aging of A2A receptor density and
of its efficiency to trigger cAMP accumulation in hippocampal
nerve terminals suggests that these changes might essentially
be a feature of the aging process rather than a slow continuous
process that evolves through maturation of the animals.
Adenosine A2A receptors were initially described as being
coupled to the GS/adenylate cyclase/cAMP/protein kinase A
pathway (Fredholm et al. 1994). However, several studies have
shown that A2A receptors can couple to different transducing
systems in different preparations, making it clear that A2A
receptors are potentially pleiotropic receptors (reviewed in
Cunha 2001). Two possibilities can be considered to under-
stand the age-related change in the transducing system oper-
ated by limbic cortical A2A receptors. One would rely on a
change in the density of GS proteins in aged hippocampal nerve
terminals, whereas the second would rely on an increase in the
number of A2A receptors. There is a slight decrease in the
density of GS proteins in the cortex of aged individuals (Young
et al. 1991), but there is a general trend for a preservation of the
efficiency to trigger cAMP formation in the cortex or hip-
pocampus of aged animals (Sugawa and May 1993; Zimmer-
man and Berg 1975). Also, the first hypothesis is not supported
by the observation that the receptor agonist, isoproterenol,
caused a similar increase in cAMP levels in hippocampal nerve
terminals of aged compared with young adult rats, in accor-
dance with the preserved function of receptors in the cortex
or hippocampus of aged animals (Dierssen et al. 1992). In
contrast, the present observation that there was a nearly dou-
bling of the binding density of A2A receptors in hippocampal
nerve terminals of aged compared with young adult rats makes
it possible that the change in receptor number could be respon-
sible for the change in the main transducing system operated by
A2A receptors in aged animals. In fact, manipulation of the
levels of different receptors in heterologous expression systems
has shown that different transducing systems can be recruited
according to the density and level of activation of these recep-
tors (reviewed in Gudermann et al. 1997). Although little is
known on the trafficking and subcellular location of A2A re-
ceptors (reviewed in Fredholm et al. 2002), it is possible that
the small number of A2A receptors in hippocampal nerve
terminals of young adult rats may be scaffolded with pathways
directed for a protein kinase C mediated attenuation of A1
receptor function (Cunha and Ribeiro 2000; Lopes et al. 1999a,
2002), whereas the increase in the number of A2A receptors in
hippocampal nerve terminals of aged rats would allow their
more generally recognized coupling to the adenylate cyclase/
cAMP/protein kinase A pathway. Furthermore, one needs to
consider the possibility that covalent modifications of the A2A
receptor, which has the longest C-terminal tail among adeno-
FIG. 6. Changes in the binding density of A2A receptors and in their ability
to increase cAMP levels in hippocampal nerve terminals. A: the average
specific binding of the A2A receptor antagonist, [3H]SCH58261, to membranes
prepared from synaptosomes derived from the hippocampus of rats at 0.5, 2, 6,
12, 18 and 24 mo, as indicated below each bar. The ordinates represent the
specific binding of [3H]SCH58261 obtained on subtraction of the nonspecific
binding, determined in the presence of 2 M XAC, from total binding. Results
are mean  SE of 3–4 experiments performed in duplicate. *P  0.05 when
compared with value obtained for 2-mo-old rats. B: the average levels of
cAMP measured in nerve terminals from rats at 0.5, 2, 6, 12, 18 and 24 mo (as
indicated below each bar) when incubated for 4 min with 2 U/ml adenosine
deaminase and 50 M rolipram without (basal, open bars) or with 300 nM
CGS21680 (filled bars). The treated synaptosomes were then inactivated and
sonicated; their cAMP levels were quantified with a radioimmunoassay kit and
the values were normalized per mg of protein. The values are mean  SE of
3–4 experiments. *P  0.05 vs. basal value within each age group.
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sine receptors (Svenningsson et al. 1999), may control the G
protein coupling of A2A receptors, an issue that has not yet
been experimentally tested.
Of direct relevance for the functional importance of the
changes in the adenosine neuromodulatory system in aged rats
is the conclusion that A2A receptors appear to be a direct
facilitatory system in aged rats compared with their predomi-
nant fine-tuning role in young adult rats (Sebastia˜o and Ribeiro
2000). Thus whereas in young adult rats the role of hippocam-
pal A2A receptors is mainly to control A1 receptor function, in
the aged rats, activation of A2A receptors causes a direct
facilitation of glutamatergic transmission. Interestingly, this
occurs in parallel with a decreased density of A1 receptors
(Cunha et al. 1995a), resulting in a decreased potency of A1
receptor agonists to modulate hippocampal synaptic transmis-
sion (Sebastia˜o et al. 2000). Thus the adenosine neuromodu-
latory system, which results from a balanced activation of
inhibitory A1 and facilitatory A2A receptors (Cunha 2001),
appears to be unbalanced toward facilitatory A2A receptors in
aged animals so as to compensate the lower neuronal efficiency
in the CA1 area of the rat hippocampus (Barnes 1994; Barnes
et al. 2000). This raises the suggestion that the adenosine
neuromodulatory system may be an adaptation system to com-
pensate for the changes in synaptic transmission that occur on
aging.
A modified A2A receptor function has also been proposed to
occur in the striatum (Corsi et al. 1999, 2000; Popoli et al.
1998a). It is important to keep in mind that the main subcel-
lular localization and functional role of striatal A2A receptors
are different from extra-striatal A2A receptors (Fredholm et al.
2002). In fact, whereas in extra-striatal areas the role of neu-
ronal A2A receptors is mostly a facilitation of neurotransmitter
release (reviewed in Cunha 2001), striatal A2A receptors have
a main postsynaptic location controlling the function of D2
receptors (Svenningsson et al. 1999) and also of NMDA re-
ceptors (Nash and Brotchie 2000). Overall, the evolution on
aging of striatal and hippocampal or cortical A2A receptors
appears to be in opposite directions. Indeed, binding studies
revealed a decreased binding density of A2A receptors in the
striatum of aged rats (Cunha et al. 1995a; Popoli et al. 1998b)
that is accompanied by a decreased expression of A2A receptor
mRNA (Schiffmann and Vanderhaeghen 1993), precisely the
opposite of what occurs for A2A receptors in the hippocampus
and cortex of aged rats (Cunha et al. 1995a; Lopes et al.
1999b). This opposite age-related change in the density of A2A
receptors in the striatum and in the cortex also raises some
concern on the therapeutic use of A2A receptor antagonists as
anti-Parkinsonian drugs (e.g., Fredholm et al. 2002). In fact, in
young adult rats that are used as models for this striatal
dysfunction, blockade of central A2A receptors is roughly
equivalent to blockade of striatal A2A receptors given the high
density of striatal versus extra-striatal A2A receptors (Sven-
ningsson et al. 1999). However, Parkinson’s disease is preva-
lent in aged individuals and we presently observed that there is
a marked increase in the density and functional impact of A2A
receptors in the hippocampus and in the cortex (see also Lopes
et al. 1999b), whereas the opposite is observed in the striatum
(Cunha et al. 1995a; Popoli et al. 1998b). This brings to stage
the possible more evident side effects of long-term adminis-
tration of A2A receptor antagonists in the elderly, namely in
view of the observed effects of A2A receptors in the control of
hippocampal synaptic plasticity (de Mendonc¸a and Ribeiro
1994), sleep (Satoh et al. 1999), and psychosis (Ferre´ et al.
1994; Sills et al. 2001).
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